Scoliosis development in 5q-spinal muscular atrophy under disease modifying therapies
The observations made in this study suggest that the effects of SMA therapies do not prevent scoliosis development. The improved prognosis may lead to a growing cohort of SMA type 1 and 2 patients with early onset scoliosis who require early growth-friendly surgical interventions.
Authors
- Matthias Pumberger (ORCID: https://orcid.org/0000-0002-0885-7370)
- Carsten Perka (ORCID: https://orcid.org/0000-0002-0993-581X)
- Lukas Schönnagel (ORCID: https://orcid.org/0000-0002-0743-8860)
- Paul Köhli (ORCID: https://orcid.org/0000-0001-7473-6553)
- Claudia Weiß (ORCID: https://orcid.org/0000-0001-6167-5878)
- Tu‐Lan Vu‐Han
Institutions
- Zuse Institute Berlin (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- European Spine Journal
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1007/s00586-024-08586-y
- Citations
- 1
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- Deutsche Forschungsgemeinschaft
- Charité – Universitätsmedizin Berlin
- Berlin Institute of Health